LakeShore Biopharma
Global biopharmaceutical company focused on scaling up undersupplied vaccines and developing new biologics to address critical global health needs.
Location
Shanghai, China & Bridgewater, New Jersey, USA
Founded
2021
Investors
1
Categories
vaccines, biologics, global-health, manufacturing, biopharma
Notes
LakeShore Biopharma is a global biopharmaceutical company dedicated to addressing critical global health needs through the development and scaled manufacturing of vaccines and biologics. The company focuses on bringing essential vaccines to underserved markets and developing new biologic therapies.
With operations in both China and the United States, LakeShore Biopharma combines global reach with local manufacturing capabilities to improve access to critical healthcare products.
Team
- Chang Yi Wang, Ph.D. - Chief Executive Officer
- LinkedIn: linkedin.com/in/changyi-wang
Additional Research Findings
- Founded in 2021
- Dual headquarters in Shanghai, China and Bridgewater, New Jersey, USA
- Backed by Bain Capital Life Sciences
- Focus on scaling undersupplied global health vaccines
- Developing new biologics for unmet medical needs
- Global manufacturing capabilities for vaccine production
- Addressing vaccine access challenges in emerging markets
Sources
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Adjuvant Capital | Washington, DC, USA | biotech-focused | seedseries-a+3 | 16 |